BERLIN, March 3 (Reuters) – Swiss pharmaceutical company Roche (ROG.S), opens new tab is aiming for a double-digit market share in the weight loss market and wants to close the gap on its Danish rival Novo Nordisk (NOVOb.CO), opens new tab, its CEO told Germany’s Handelsblatt business daily.
“We expect to be among the top three in the market at the very least,” Roche Chief Executive Thomas Schinecker said in an interview with the newspaper published on Tuesday.
Sign up here.
Writing by Linda Pasquini; Editing by Christopher Cushing
Our Standards: The Thomson Reuters Trust Principles., opens new tab